Cancer registration, molecular marker status and adherence to the WHO 2016 classification of pathology reports for glioma diagnosed during 2017-2019 in Belgium
Conclusion:
Both the integration of molecular markers in the conclusion of the pathology reports and the delivery of those reports to the BCR can be improved. The availability of distinct ICD-O-3 codes for each molecularly defined tumour entity within the WHO classification would increase the consistency of cancer registration, facilitate population level research and international benchmarking.
Source: Pathobiology - Category: Pathology Source Type: research
More News: Belgium Health | Brain Tumor | Cancer | Cancer & Oncology | Databases & Libraries | Glioma | Pathology | Study